Literature DB >> 10673166

Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease.

P J Barnes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673166     DOI: 10.1164/ajrccm.161.2.16125_2

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  37 in total

1.  The tobacco smoke component acrolein induces glucocorticoid resistant gene expression via inhibition of histone deacetylase.

Authors:  Matthew J Randall; Guido R M M Haenen; Freek G Bouwman; Albert van der Vliet; Aalt Bast
Journal:  Toxicol Lett       Date:  2015-10-19       Impact factor: 4.372

Review 2.  Chronic obstructive pulmonary disease * 12: New treatments for COPD.

Authors:  P J Barnes
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

Review 3.  Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options.

Authors:  M Friedman; D E Hilleman
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

4.  Effects of fluticasone propionate on inflammatory cells in COPD: an ultrastructural examination of endobronchial biopsy tissue.

Authors:  M J Gizycki; K L Hattotuwa; N Barnes; P K Jeffery
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

Review 5.  Inhaled corticosteroids in the long-term management of patients with chronic obstructive pulmonary disease.

Authors:  Don D Sin; S F Paul Man
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 6.  Therapy for chronic obstructive pulmonary disease in the 21st century.

Authors:  Louise E Donnelly; Duncan F Rogers
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 7.  Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies.

Authors:  Marc Miravitlles; Antonio Anzueto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-05-07

8.  Predictive value and utility of oral steroid testing for treatment of COPD in primary care: the COOPT study.

Authors:  Niels H Chavannes; Tjard R J Schermer; Emiel F M Wouters; Reinier P Akkermans; Richard P N Dekhuijzen; Jean W M Muris; Chris van Weel; Onno C P van Schayck
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29

Review 9.  Budesonide-formoterol (inhalation powder) in the treatment of COPD.

Authors:  Erkan Ceylan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

Review 10.  Pharmacological treatment of chronic obstructive pulmonary disease.

Authors:  Paolo Montuschi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.